AP
Akesis Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Fine Stuart A, was filed 16 Oct 2008.
Akesis Pharmaceuticals, Inc.: what insiders have been doing
Akesis Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Akesis Pharmaceuticals, Inc. has had no insider filing for more than a year; the last one goes back to 16 October 2008.
Our records for Akesis Pharmaceuticals, Inc. go back to 2006, with 48 purchases and no sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
50
Thresholds
n/a
Buy Volume
€4M
48 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 16 October 2008
Declarations50 total
- 10,000 shares@ US$0.78Common StockSEC:0001209191-08-056584:0Canonical exit: 22 Oct 2008 (T+90)
- 2,500 shares@ US$0.80Common StockSEC:0001209191-08-056584:1Canonical exit: 22 Oct 2008 (T+90)
- 11,250 shares@ US$0.94Common StockSEC:0001209191-08-056584:2Canonical exit: 22 Oct 2008 (T+90)
- 110,050 shares@ US$0.95Common StockSEC:0001209191-08-056584:3Canonical exit: 26 Oct 2008 (T+90)
- 2,500 shares@ US$0.80Common StockSEC:0001209191-08-056584:4Canonical exit: 30 Oct 2008 (T+90)
- 19,000 shares@ US$0.85Common StockSEC:0001209191-08-056584:5Canonical exit: 30 Oct 2008 (T+90)
- 42,101 shares@ US$0.93Common StockSEC:0001209191-08-056584:6Canonical exit: 30 Oct 2008 (T+90)
- 5,000 shares@ US$0.49Common StockSEC:0001209191-08-056584:7Canonical exit: 22 Dec 2008 (T+90)
- 2,352,942 shares@ US$0.85Common StockSEC:0001116679-08-000920:0Canonical exit: 23 Jun 2008 (T+90)
- 10,000 shares@ US$0.72Common StockSEC:0001116679-07-003015:0Canonical exit: 17 Feb 2008 (T+90)
- 10,000 shares@ US$0.73Common StockSEC:0001116679-07-003015:1Canonical exit: 17 Feb 2008 (T+90)
- 5,000 shares@ US$0.55Common StockSEC:0001116679-07-002483:0Canonical exit: 11 Dec 2007 (T+90)
- 5,000 shares@ US$0.59Common StockSEC:0001116679-07-002483:2Canonical exit: 11 Dec 2007 (T+90)
- 5,000 shares@ US$0.65Common StockSEC:0001116679-07-002483:3Canonical exit: 12 Dec 2007 (T+90)
- 2,500 shares@ US$0.67Common StockSEC:0001116679-07-002483:4Canonical exit: 12 Dec 2007 (T+90)
- 2,500 shares@ US$0.55Common StockSEC:0001116679-07-002428:0Canonical exit: 9 Dec 2007 (T+90)
- 5,000 shares@ US$0.50Common StockSEC:0001116679-07-002428:4Canonical exit: 9 Dec 2007 (T+90)
- 5,000 shares@ US$0.50Common StockSEC:0001116679-07-002428:7Canonical exit: 10 Dec 2007 (T+90)
- 7,500 shares@ US$0.53Common StockSEC:0001116679-07-002428:8Canonical exit: 10 Dec 2007 (T+90)
- 5,000 shares@ US$0.46Common StockSEC:0001116679-07-002398:0Canonical exit: 5 Dec 2007 (T+90)
- 5,000 shares@ US$0.48Common StockSEC:0001116679-07-002398:1Canonical exit: 5 Dec 2007 (T+90)
- 5,000 shares@ US$0.49Common StockSEC:0001116679-07-002398:2Canonical exit: 5 Dec 2007 (T+90)
- 5,000 shares@ US$0.46Common StockSEC:0001116679-07-002379:0Canonical exit: 3 Dec 2007 (T+90)
- 5,000 shares@ US$0.47Common StockSEC:0001116679-07-002379:1Canonical exit: 3 Dec 2007 (T+90)
- 5,000 shares@ US$0.48Common StockSEC:0001116679-07-002379:2Canonical exit: 3 Dec 2007 (T+90)
25 of 50 declarations
About Akesis Pharmaceuticals, Inc.
Akesis Pharmaceuticals, Inc. is a company focused on developing treatments for health-related diseases. It is listed on NASDAQ under the symbol XNAS.
